Loading…
Asensus Surgical has entered into a non-binding letter of intent with KARL STORZ SE & Co. KG for KARL STORZ to acquire 100% of Asensus common stock for $0.35 per share in cash, representing a 66.7% premium. A bridge loan of up to $20 million has been provided.